Titel

Merkliste
1 Ergebnisse

Overall survival with durvalumab after chemoradiotherapy in..:

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey...
Antonia , S J , Villegas , A , Daniel , D , Vicente , D , Murakami , S , Hui , R , Kurata , T , Chiappori , A , Lee , K H , De Wit , M , Cho , B C , Bourhaba , M , Quantin , X , Tokito , T , Mekhail , T , Planchard , D , Kim , Y , Karapetis , C S , Hiret , S , Ostoros , G , Kubota , K , Gray , J E , Paz-ares , L , De Castro Carpeño , J , Faivre-finn , C , Reck , M , Vansteenkiste , J , Spigel , D R , Wadsworth , C , Melillo , G , Taboada , M , Dennis , P A & Özgüroğlu , M 2018 , ' Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC : Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC ' , New England Journal Of Medicine , vol. 379 , no. 24 , pp. 2342-2350 . https://doi.org/10.1056/NEJMoa1809697. , 2018

Link: https://research.manchester.ac.uk/en/publications/93c1..

RT Journal
T1 <Title>Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC:Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftumanchesterpub:oai:pure.atira.dk:publications_93c11175-f1d4-4de5-a579-d1f0064d6ddb&Exemplar=1&LAN=DE
				
A1 Antonia, Scott J
A1 Villegas, Augusto
A1 Daniel, Davey
A1 Vicente, David
A1 Murakami, Shuji
A1 Hui, Rina
A1 Kurata, Takayasu
A1 Chiappori, Alberto
A1 Lee, Ki H
A1 De Wit, Maike
A1 Cho, Byoung C
A1 Bourhaba, Maryam
A1 Quantin, Xavier
A1 Tokito, Takaaki
A1 Mekhail, Tarek
A1 Planchard, David
A1 Kim, Young-chul
A1 Karapetis, Christos S
A1 Hiret, Sandrine
A1 Ostoros, Gyula
A1 Kubota, Kaoru
A1 Gray, Jhanelle E
A1 Paz-ares, Luis
A1 De Castro Carpeño, Javier
A1 Faivre-finn, Corinne
A1 Reck, Martin
A1 Vansteenkiste, Johan
A1 Spigel, David R
A1 Wadsworth, Catherine
A1 Melillo, Giovanni
A1 Taboada, Maria
A1 Dennis, Phillip A
A1 Özgüroğlu, Mustafa
YR 2018
K1 ResearchInstitutes_Networks_Beacons/mcrc
K1 Manchester Cancer Research Centre
JF Antonia , S J , Villegas , A , Daniel , D , Vicente , D , Murakami , S , Hui , R , Kurata , T , Chiappori , A , Lee , K H , De Wit , M , Cho , B C , Bourhaba , M , Quantin , X , Tokito , T , Mekhail , T , Planchard , D , Kim , Y , Karapetis , C S , Hiret , S , Ostoros , G , Kubota , K , Gray , J E , Paz-ares , L , De Castro Carpeño , J , Faivre-finn , C , Reck , M , Vansteenkiste , J , Spigel , D R , Wadsworth , C , Melillo , G , Taboada , M , Dennis , P A & Özgüroğlu , M 2018 , ' Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC : Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC ' , New England Journal Of Medicine , vol. 379 , no. 24 , pp. 2342-2350 . https://doi.org/10.1056/NEJMoa1809697
LK http://dx.doi.org/https://research.manchester.ac.uk/en/publications/93c11175-f1d4-4de5-a579-d1f0064d6ddb
DO https://research.manchester.ac.uk/en/publications/93c11175-f1d4-4de5-a579-d1f0064d6ddb
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)